NCI-H2126 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The NCI-H2126 cell line is derived from a human large cell carcinoma, a subtype of non-small cell lung cancer (NSCLC). Originating from the lung tissue of a male patient, this cell line exhibits characteristics typical of large cell carcinomas, including poorly differentiated, undifferentiated cellular features. It is an important model for understanding the genetic and molecular mechanisms underlying large cell lung cancers and for testing therapeutic agents targeting this NSCLC subtype. Genomic studies on NCI-H2126 have identified frequent allelic losses and chromosomal aberrations, such as deletions on chromosome arms 6q and 13q, which are commonly implicated in tumor suppressor gene inactivation in NSCLC. These genetic alterations contribute to the disruption of key regulatory pathways, including those involved in cell cycle control and apoptosis. The cell line has been employed in comparative studies to distinguish patterns of chromosomal loss across different lung cancer subtypes, enhancing the understanding of NSCLC-specific molecular signatures. NCI-H2126 has also been included in extensive drug screening programs to evaluate its sensitivity and resistance to various chemotherapeutic agents and targeted therapies. The cell line’s genetic profile and its tumorigenic potential in xenograft models make it a valuable resource for preclinical studies focused on the development and refinement of treatments for large cell carcinoma and other forms of NSCLC. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Large cell carcinoma |
| Metastatic site | Pleural effusion |
| Applications | 3D cell culture, Cancer research |
| Synonyms | H-2126, NCIH2126, NCI-H2126 |
Characteristics
| Age | 65 years |
|---|---|
| Gender | Male |
| Ethnicity | European |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | NCI-H2126 (Cytion catalog number 300639) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1532 |
Biomolecular Data
| Isoenzymes | AK-1, 1, ES-D, 1-2, G6PD, B, GLO-I, 2, Me-2, 0, PGM1, 1-2, PGM3, 2 |
|---|---|
| Tumorigenic | Yes, in nude mice |
| Viruses | EBV (Transformant) |
| Ploidy status | Hypertriploid |
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 5% FBS, 0.005 mg/mL Insulin, 0.01 mg/mL Transferrin, 30nM Sodium selenite, 10 nM Hydrocortisone, 10 nM beta-estradiol |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300639-230623 | Certificate of Analysis | 23. May. 2025 | 300639 |
-
Related products
Related products